Neurology Expertise

Learn how we helped our client understand the opportunity of their technology and pipeline in acute neuronal injuries, including a US forecast model that conveyed potential long-term revenue.

Discover how we helped our client understand the current market landscape and product opportunity in the US epilepsy space.

A top-15 biopharmaceutical company with an early-stage Central Nervous System (CNS) therapy had established two anticipated launch scenarios: accelerated and delayed timelines. They needed to create a brand plan that was built on a foundational understanding of the current disease area, market needs, and competitive landscape, while integrating alternative launch scenarios inclusive of regulatory hurdles to maximize preparedness. Learn how Lumanity helped.

A European medical technology and pharmaceutical company with an approved sedative for anesthesia in Europe aimed to enter the US market. They came to Lumanity to understand the key differences between commercializing in Europe and the US, as well as understand the potential value of the US opportunity and the investment requirements, to determine how to approach organizational scale-up and level-set on revenue expectations. Discover how we helped.

Our client was evaluating an investment in neurology CROs and SMOs and needed to understand the implications of investing in each type of organization, as well as the current and future neurology clinical development landscape, how CROs and SMOs support neurology-focused clinical trials, and drivers and barriers of the evolution of neurology clinical development. Learn how Lumanity helped.